A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Brivaracetam Impurity 14 - Request Quote

Picture of Brivaracetam Impurity 14

Brivaracetam Impurity 14

SZ CAT No:SZ-B039025
CAS No
NA
Mol.F.
C11H17NO4
Mol.Wt.
227.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Brivaracetam Impurity 14 is chemically (2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid. Brivaracetam Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Brivaracetam Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Brivaracetam.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Brivaracetam Impurity 14

Purchase Brivaracetam Impurity 14

Brivaracetam Impurity 14 suppliers

Brivaracetam Impurity 14 manufacturers

Brivaracetam Impurity 14 price

Order Brivaracetam Impurity 14

Enquire Brivaracetam Impurity 14

Brivaracetam Impurity 14 cost

Brivaracetam Impurity 14 Supplier

Brivaracetam Impurity 14 Distributor

Brivaracetam Impurity 14 for Method Validation

Brivaracetam Reference Standard

Brivaracetam Impurity 14 for ANDA Filing

Brivaracetam Impurity 14 for Forced Degradation Studies

Brivaracetam Impurity 14 Identification Standards

Brivaracetam Impurity 14 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,